Myoflex (trolamine salicylate) 10%, Pain Relieving Cream, a) 2-oz tube, b) 4-oz. tube, OTC. The firm name on the label is Novartis Consumer Health, Inc., Parsippany, NJ 07054.

Labeling: Incorrect or Missing Lot and/or Exp Date. The lot number and/or expiration date may be illegible.

Recall #: D-207-2013
Affected scope: 240,120/2-oz. tubes and 429,144/4-oz. tubes
Initiated: March 7, 2013

Compiled from official public sources by the publisher. · Updated September 2026

Novartis Consumer Health recalled Myoflex (trolamine salicylate) 10%, Pain Relieving Cream, a) 2-oz tube, b) 4-oz. tube, OT… - a low-severity action.

Myoflex (trolamine salicylate) 10%, Pain Relieving Cream, a) 2-oz tube, b) 4-oz. tube, OT… was recalled by Novartis Consumer Health in March 27, 2013. Reason: Labeling: Incorrect or Missing Lot and/or Exp Date. The lot number and/or expiration date may be illegible.. Check the official notice for the remedy. Verify recall #D-207-2013 with the FDA Drug before acting.

The recall

Novartis Consumer Health issued this low-severity FDA Drug recall-Labeling: Incorrect or Missing Lot and/or Exp Date. The lot number and/or expiration date may be illegible..

Low
severity level: Class III
classification: March 27, 2013
reported

Sourced from official FDA Drug enforcement records. Verify recall #D-207-2013 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This recall's affected scope, documented in the Recall Profile below, stays within a single-region or limited-distribution footprint. Distribution scope (see Distribution below) directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls, 3 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Where this agency-classified recall sits among FDA Class I/II/III notices

Of 88,244 recalls with an agency hazard classification, 19,068 are high severity, 64,652 moderate, and 4,524 low. A further 16,179 CPSC/NHTSA recalls have no agency class and are excluded from this split. This recall is classified low severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Product description

Myoflex (trolamine salicylate) 10%, Pain Relieving Cream, a) 2-oz tube, b) 4-oz. tube, OTC. The firm name on the label is Novartis Consumer Health, Inc., Parsippany, NJ 07054.

Reason for recall

Labeling: Incorrect or Missing Lot and/or Exp Date. The lot number and/or expiration date may be illegible.

Recall Profile

Structured summary of the FDA Drug recall record
Attribute	Value
Agency	U.S. Food and Drug Administration
Severity class	Low (Class III)
Status	Terminated
Recall number	D-207-2013
Date reported	March 27, 2013
Date initiated	March 7, 2013
Recalling firm	Novartis Consumer Health
Firm location	Lincoln, NE
Affected scope	240,120/2-oz. tubes and 429,144/4-oz. tubes
Distribution	Nationwide and Panama

Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

Check the recall number (D-207-2013) and product description against the item you own. Search the archive
Confirm the current status with FDA Drug before acting, recall details can be updated.
Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled? ▼

Myoflex (trolamine salicylate) 10%, Pain Relieving Cream, a) 2-oz tube, b) 4-oz. tube, OTC. The firm name on the label is Novartis Consumer Health, Inc., Parsippany, NJ 07054.. Recalled by Novartis Consumer Health. Units affected: 240,120/2-oz. tubes and 429,144/4-oz. tubes.

Why was this product recalled? ▼

Labeling: Incorrect or Missing Lot and/or Exp Date. The lot number and/or expiration date may be illegible.

Which agency issued this recall? ▼

This recall was issued by the FDA Drug on March 27, 2013. Severity: Low. Recall number: D-207-2013.

Where was the recalled product distributed? ▼

Distribution: Nationwide and Panama.

Should I stop using a recalled medication or medical device? ▼

Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nationwide recalls with similar severity or category timing

Drug and device notices outside this firm and state, matched by severity timing and product category.

Similar severity · nearest report date

Same archive severity grade (Low), closest by report date among other firms and states.

Carisoprodol Tablets, USP, 350 mg Rx Only… 2013-03-27 MET-Rx EXTREME NOS PUMPED WATERMELON Natu… 2013-03-27 MET-Rx EXTREME NOS PUMPED DOUBLE BERRY Na… 2013-03-27 MET-Rx EXTREME NOS PUMPED NITRO-PUNCH Nat… 2013-03-27

Similar Cosmetics & Personal Care · nearest report date

Same product category, closest by report date among other firms and states (deduped against the severity set).

Pascalite Powder 8 oz, 16 oz, 5 lb, and 2… 2013-03-27 Ruthies Cranberry Orange Breakfast Cookie… 2013-04-03 Publix 7 inch Chocolate Cookies n Cream C… 2013-03-20 Publix 7 inch Cookies Cream Layer Cake S… 2013-03-20

Compare this recall with Ice Pop, D'Dioses Cookies Cream, 1 Bar (81.7 g), with UPC 7… → · All Cosmetics & Personal Care recalls

This recall: FDA Drug, reported March 27, 2013. Severity classes follow each agency's own taxonomy; related-recall context is computed across the full archive.

Methodology · Corrections · Archive as of August 2026